Specialist in Emerging Markets Health Care


The Executive


Investment support

Value added

Successful investment track record.


Structured approach using bespoke evaluation tools.


Comprehensive assessment of market and business operations.


High degree of reassurance,  supported by evidence-based analysis and conclusions.

Across the globe spending on health care continues to grow strongly - driven by rapidly aging populations, availability of new technologies, and rising incomes and expectations.  Nowhere is this more evident than in emerging markets.  As a result, the health sector offers potentially very attractive investment, and social, returns – evidenced, in recent years, by scores of listings and the emergence of several international health care companies.  

Policlinik female doc v2

We specialize in support to all phases of the investment/M&A project cycle including:

initial project identification and screening

due diligence and feasibility analysis


performance improvement and turnaround

business strategy formulation and execution


Refined and tested over several years we have developed a robust process for due diligence assessment which encompasses:

governance and management

market assessment

business strategy

regulatory environment

business model

facilities model

services model

performance (including financial, utilization and efficiency)

performance improvement potential

growth potential

HR/staffing issues

risk assessment (including business, clinical, environmental, insurance)

Max building site
Arab doctors walking